WASHINGTON (HealthDay News) -- Australian researchers say they've found
a new marker for identifying aggressive prostate cancer.

"Men who have low levels of a marker called AZGP1 in the prostate at the
time of [prostate removal] surgery have a greatly increased risk of
developing metastatic cancer," Sue Henshall, leader of the prostate
cancer research group at the Garvan Institute in Sydney, said in a
prepared statement.

"This means two things: that these men could benefit from more
aggressive treatment such as radiotherapy or chemotherapy around the
time of surgery when they still have potentially curable cancer; and
that patients with a low risk of developing metastatic disease will have
the option of deferring treatments that have a negative impact on
quality of life," Henshall added.

The next step of this research is to study the association between AZGP1
levels and metastatic cancer in prostate cancer patients who don't have
surgery, the researchers said.

knowledge is power - growing old is mandatory - growing wise is optional    
"Many more men die with prostate cancer than of it. Growing old is
invariably fatal. Prostate cancer is only sometimes so."
http://community.webtv.net/PALMER_ENT/doc